Prelude Capital Management, LLC Zoetis Inc. Transaction History

Prelude Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$155.97 - $200.09 $927,085 - $1.19 Million	5,944 New	5,944 $1.02 Million
Q4 2020 Feb 16, 2021	SELL	$157.07 - $174.35 $29,843 - $33,126	-190 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$137.1 - $165.37 $19,056 - $22,986	-139 Reduced 42.25%	190 $31,000
Q2 2020 Aug 14, 2020	BUY	$111.92 - $142.53 $36,821 - $46,892	329 New	329 $45,000
Q1 2019 May 15, 2019	SELL	$81.56 - $100.67 $5,709 - $7,046	-70 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$79.28 - $95.27 $5,549 - $6,668	70 New	70 $6,000
Q4 2017 Feb 14, 2018	SELL	$63.24 - $72.8 $869,233 - $1 Million	-13,745 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$59.73 - $65.4 $820,988 - $898,923	13,745	13,745 $876,000

1,956

412M

1.02M

1.09M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $82.8B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.